Blood marker of cancer returned to normal in just one month
An article in Gynecologic Oncology Reports (Aug. 2019) said an 81-year-old woman with a rare and deadly form of ovarian cancer was “clinically asymptomatic” after she began treating herself with CBD and containing amygdaline (derived from plant and fruit seed).
“Basic science studies have identified cannabinoid receptors in ovarian cancer as potential therapeutic targets for cannabinoid use in treating malignancy.
The case study profiled in the article was provided by UC San Diego Moores Cancer Center, La Jolla, California.
Since 2011, CBD has been shown to decrease prostate and ovarian cancer cells.